ARCHIVED Medical devices for use in relation to COVID-19: Cancellation
On January 3, 2024, Health Canada introduced the Regulations Amending the Medical Devices Regulations (Medical Devices for an Urgent Public Health Need). These regulations broaden the scope of Part 1.1 of the Medical Devices Regulations to apply to other public health emergencies. For more information, please refer to the notice.
On this page
Cancellation
The Minister may cancel the authorization for importing and selling a COVID-19 medical device if:
- the Minister has reasonable grounds to believe that:
- the authorization holder has contravened the Act or the Regulations
- the risks outweigh the benefits associated with the device having regard to
- the uncertainties relating to the benefits and risks and
- the UPHN or absence of UPHN for the device
- the authorization holder does not have an adequate quality management system (QMS) in place
- the health or safety of patients, users or other persons may be unduly affected by the device or
- the authorization holder failed to comply with the terms and conditions of the authorization
- if the authorization was issued on the basis of subsection 68.11(4), the authorization or licence for sale of the COVID-19 medical device that has been issued by a foreign regulatory agency is suspended or cancelled
- the authorization holder does not submit additional information, documents or material to the Minister within the time limit specified in the request or
- the authorization holder does not meet additional requirements within the prescribed timelines after their medical device is removed from the UPHN list or is not included on the UPHN list when the list first becomes available
The manufacturer will be able to voice any concerns related to the Minister's decision to cancel the authorization before Health Canada issues the final decision. We will then inform the authorization holder in writing of our final decision.
Health Canada will implement compliance and enforcement measures if a COVID-19 medical device authorized for importation or sale under Part 1.1 of the MDR is in noncompliance.
We will cancel an authorization when:
- the authorization holder of a Class I COVID-19 medical device has been issued an MDEL under Part 1 of the MDR
- the authorization holder of a Class II, III or IV COVID-19 medical device has been issued an MDL for the same device under Part 1 of the MDR or
- the authorization holder informs the Minister that the sale of the device has been discontinued in Canada or requests that the authorization be cancelled
Health Canada publishes and maintains a list of COVID-19 medical devices that are no longer authorized in Canada. Authorizations may have been cancelled for some medical devices that were initially authorized under the first, second or third interim order. New devices may be added to the list as required.
Sell-off period
A manufacturer of a Class I device will no longer be allowed to sell the medical device when an authorization under Part 1.1 of the MDR is cancelled because:
- the manufacturer of the device that is not on the UPHN list did not apply for an MDEL within the prescribed timeline
- the Minister refused to issue an MDEL to the manufacturer or
- the manufacturer withdraws their MDEL application
A manufacturer the Class II, III or IV device will no longer be allowed to sell the medical device when an authorization under Part 1.1 of the MDR is cancelled because:
- the manufacturer of that device that is not on the UPHN list did not provide the signed certification contract or
- the manufacturer did not provide the Minister with a copy of the MDSAP-compliant QMS certificate within the prescribed timelines
However, importers, distributors and retailers of the device will be able to continue selling off existing stock for another 6 months, as long as the stock complies with labelling requirements and the relevant importer(s) and distributor(s) hold an active MDEL.
During this additional 6-month period, since they hold an MDEL, importers and distributors of the device would still be required to comply with applicable sections of the MDR.
Page details
- Date modified: